A Comprehensive Review of Carbazole Based Heterocyclic Hybrids in Multi Target Drug Design
Authors
Student Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram. (India)
Professor, Department of Pharmaceutical Chemistry, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram. (India)
HOD, Professor, Department of Pharmaceutical Chemistry, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram. (India)
Principal, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram. (India)
Article Information
DOI: 10.51244/IJRSI.2026.1308000215
Subject Category: pharmaceutical chemistry
Volume/Issue: 13/8 | Page No: 3512-3529
Publication Timeline
Submitted: 2026-08-29
Accepted: 2026-09-03
Published: 2026-09-16
Abstract
The growing prevalence of multifactorial diseases such as Alzheimer’s disease, cancer, diabetes, microbial infections and inflammatory disorders has highlighted the limitations of the conventional one drug one target therapeutic approach. As a result, multi target directed ligands (MTDL) have become a viable tactic for concurrently modifying several pathogenic pathways implicated in development of disease. Because of the tricyclic aromatic structure, favourable lipophilicity, ease of functionalization and variety of pharmacological actions, carbazole has gained significant attention among the several heterocyclic scaffolds investigated in medicinal chemistry. The carbazole nucleus is a desirable platform for hybrid drug discovery because of its exceptional neuroprotective, antioxidant, anticancer, antibacterial, anti-inflammatory and antidiabetic properties. This review highlights recent advances in the development of carbazole based heterocyclic hybrids as multifunctional therapeutic agents. Various molecular hybridization strategies involving carbazole conjugation with pharmacologically relevant scaffolds such as tacrine, stilbene, quinolinium, chromene, indole, pyridine, triazole, quinoline and pyrazoline are discussed. The influence of linker architecture, electronic modifications and substitution pattern on biological activity is also examined. The findings demonstrate that carbazole-based hybrid design can effectively interact with multiple biological targets and offering enhanced efficacy, reduced toxicity and improved pharmacological profiles. Overall, carbazole based heterocyclic scaffold represent a versatile and promising class of compounds for the development of next generation therapeutics aimed at the management of complex diseases.
Keywords
Carbazole, MTDL, Alzheimer’s disease, Anticancer, Anti-inflammatory
Downloads
References
1. Bachurin, S. O., Shevtsova, E. F., Makhaeva, G. F., Grigoriev, V. V., Boltneva, N. P., Kovaleva, N. V., ... & Aliev, G. (2017). Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment. Scientific reports, 7(1), 45627. [Google Scholar] [Crossref]
2. Ivasiv, V., Albertini, C., Gonçalves, A. E., Rossi, M., & Bolognesi, M. L. (2019). Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases. Current Topics in Medicinal Chemistry, 19(19), 1694-1711. [Google Scholar] [Crossref]
3. Kumar, N., Gupta, P., & Bansal, S. (2022). Progress and development of carbazole scaffold based as potential anti-alzheimer agents using MTDL approach. Letters in Drug Design & Discovery, 19(12), 1049-1067. [Google Scholar] [Crossref]
4. Luo, S., Peng, Z., & Wang, G. (2026). Construction and biological evaluation of novel carbazole-5-phenyl-1, 3, 4-oxadiazole derivatives as multi-target hypoglycemic agents. European Journal of Medicinal Chemistry, 118615. [Google Scholar] [Crossref]
5. Knölker, H. J., & Reddy, K. R. (2008). Biological and pharmacological activities of carbazole alkaloids. The alkaloids: chemistry and biology, 65, 181-193. [Google Scholar] [Crossref]
6. Al-Kaissy, W. W., Safaa, H. F., & Suaad, M. H. (2013). Synthesis, characterization and evaluation of antimicrobial activity of some new acetylenic amine and 2-oxoazetidine of carbazole. Am. J. Sci. Ind. Res, 4(4), 389-398. [Google Scholar] [Crossref]
7. de Sena Murteira Pinheiro, P., Franco, L. S., Montagnoli, T. L., & Fraga, C. A. M. (2024). Molecular hybridization: a powerful tool for multitarget drug discovery. Expert Opinion on Drug Discovery, 19(4), 451-470. [Google Scholar] [Crossref]
8. Tiwari, A., & Mishra, B. (2024). Diverse pharmacological actions of potential carbazole derivatives by influencing various pathways of molecular signaling. Future Journal of Pharmaceutical Sciences, 10(1), 77. [Google Scholar] [Crossref]
9. Jose, E., Francis, P., Joy, M., Joseph, S., & Sukumaran, S. (2022). An Insight Into the Chemistry and Pharmacological Activities of Carbazole Derivatives: A Review. Indian Journal of Natural Sciences, 13, 40594. [Google Scholar] [Crossref]
10. Xu, Z., Wu, D., Fang, C., & Li, Y. (2023). Mini-review on the novel synthesis and potential applications of carbazole and its derivatives. Designed monomers and polymers, 26(1), 90-105. [Google Scholar] [Crossref]
11. Mishra, C. B., Gusain, S., Shalini, S., Kumari, S., Prakash, A., Kumari, N., ... & Tiwari, M. (2020). Development of novel carbazole derivatives with effective multifunctional action against Alzheimer’s diseases: Design, synthesis, in silico, in vitro and in vivo investigation. Bioorganic Chemistry, 95, 103524. [Google Scholar] [Crossref]
12. S. Tsutsumi, L., Gündisch, D., & Sun, D. (2016). Carbazole scaffold in medicinal chemistry and natural products: a review from 2010-2015. Current Topics in Medicinal Chemistry, 16(11), 1290-1313. [Google Scholar] [Crossref]
13. Karaaslan, C., Ince, E., Gurer-Orhan, H., Tavakkoli, M., Firuzi, O., Saso, L., & Suzen, S. (2019). Behaviour of 9-Ethyl-9H-carbazole hydrazone derivatives against oxidant systems: Protective effect on amyloid β-induced damage. Croatica Chemica Acta, 92(1), 87-94. [Google Scholar] [Crossref]
14. Bhandari, D. D., Kaur, P., Maan, M., Garg, R., Chopra, H., & Kamal, M. A. (2024). Neuroprotective potential of heterocyclic scaffolds vs herbal treatments: An overview. Research Journal of Pharmacy and Technology, 17(6), 2943-2948. [Google Scholar] [Crossref]
15. Reshma, H. P., Emmanuel, B. D., Beevi, J., & Dharan, S. S. (2021). Insilico design, synthesis and biological evaluation of novel carbazole derivatives. J. Pharm. Sci. Res, 13, 8-18. [Google Scholar] [Crossref]
16. Kaplancikli, Z. A., Yurttaş, L., Turan-Zitouni, G., Özdemir, A., Özic, R., & Ulusoylar-Yıldırım, Ş. (2012). Synthesis, antimicrobial activity and cytotoxicity of some new carbazole derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(6), 868-874. [Google Scholar] [Crossref]
17. Zhang, F. F., Gan, L. L., & Zhou, C. H. (2010). Synthesis, antibacterial and antifungal activities of some carbazole derivatives. Bioorganic & medicinal chemistry letters, 20(6), 1881-1884. [Google Scholar] [Crossref]
18. Pai, V., Shreedhara, C. S., Chandrashekar, K. S., Pai, A., & Kamath, V. (2016). Cognitive enhancement and neuroprotective effects of ancient ayurvedic medicinal plant celastrus paniculatus: an overview. Research Journal of Pharmacy and Technology, 9(8), 1295-1298. [Google Scholar] [Crossref]
19. Basnet, M., Yogesh, H. S., & Swamy, S. (2020). Evaluation of Neuroprotective activity of Bougainvillea glabra leaves extract on experimentally induced Neurotoxicity in Albino rats. Research Journal of Pharmacy and Technology, 13(8), 3825-3832. [Google Scholar] [Crossref]
20. Sahu, M., Kumar, V., & Joshi, V. (2021). Indian medicinal plants with antidiabetic potential: An overview. Research Journal of Pharmacy and Technology, 14(4), 2328-2335. [Google Scholar] [Crossref]
21. Bashir, M., Bano, A., Ijaz, A. S., & Chaudhary, B. A. (2015). Recent developments and biological activities of N-substituted carbazole derivatives: a review. Molecules, 20(8), 13496-13517. [Google Scholar] [Crossref]
22. Shah, D., Patel, M., Vyas, A., & Patel, A. (2025). Sustainable Strategies for Carbazole Synthesis: A Green Chemistry Perspective. Archiv der Pharmazie, 358(9), e70096. [Google Scholar] [Crossref]
23. Al Amin, N. R., Gnanasekaran, P., Chang, Y. J., & Chang, C. H. (2026). Carbazole-based host materials for red to near-infrared OLEDs: molecular design strategies and structure–property relationships. Journal of Materials Chemistry C, 14(25), 10907-10943. [Google Scholar] [Crossref]
24. Shaikh, M. S., Palkar, M. B., Patel, H. M., Rane, R. A., Alwan, W. S., Shaikh, M. M., ... & Karpoormath, R. (2014). Design and synthesis of novel carbazolo–thiazoles as potential anti-mycobacterial agents using a molecular hybridization approach. RSC advances, 4(107), 62308-62320. [Google Scholar] [Crossref]
25. Mathew, D., Sasidharan, S., Saudagar, P., Sujatha, S., & Parameswaran, P. (2023). meso-Carbazole decorated BODIPYs–an electron donor–acceptor system with excellent fluorosolvato/vapochromic behavior, aggregation-induced emission, and antileishmanial activity. New Journal of Chemistry, 47(17), 8277-8290. [Google Scholar] [Crossref]
26. Samala, A., Murthy, S. M., & Gottumukkala, K. M. (2018). A comprehensive review on recent advances in synthesis and pharmacotherapeutic potential of betacarbolines. Research Journal of Pharmacy and Technology, 11(8), 3547-3560. [Google Scholar] [Crossref]
27. Kleinhans, G., Karhu, A. J., Boddaert, H., Tanweer, S., Wunderlin, D., & Bezuidenhout, D. I. (2023). LNL-Carbazole pincer ligand: more than the sum of its parts. Chemical Reviews, 123(13), 8781. [Google Scholar] [Crossref]
28. Takeuchi, T., Oishi, S., Watanabe, T., Ohno, H., Sawada, J. I., Matsuno, K., ... & Fujii, N. (2011). Structure–activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors. Journal of medicinal chemistry, 54(13), 4839-4846. [Google Scholar] [Crossref]
29. Liu, Y., Zhang, J., Tian, J., Wang, C., Wang, T., Gong, J., & Hu, L. (2024). Structure-activity relationship study of new carbazole sulfonamide derivatives as anticancer agents with dual-target mechanism. European Journal of Medicinal Chemistry, 273, 116509. [Google Scholar] [Crossref]
30. Monica Moore, M., Díaz-Santos, M., & Vossel, K. (2021). Alzheimer’s association 2021 facts and figures report. Alzheimer’s association, 17(3), 327-406. [Google Scholar] [Crossref]
31. Kumar, N., Gupta, P., & Bansal, S. (2022). Progress and development of carbazole scaffold based as potential anti-alzheimer agents using MTDL approach. Letters in Drug Design & Discovery, 19(12), 1049-1067. [Google Scholar] [Crossref]
32. Kuruvella, S., & Yellu, N. R. (2024). Naringi crenulata leaf extract alleviates Beta Amyloid Protein Induced Alzheimers disease in mice. Research Journal of Pharmacy and Technology, 17(6), 2732-2738. [Google Scholar] [Crossref]
33. Vermunt, L., Sikkes, S. A., Van Den Hout, A., Handels, R., Bos, I., Van Der Flier, W. M., ... & ICTUS/DSA study groups. (2019). Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimer's & Dementia, 15(7), 888-898. [Google Scholar] [Crossref]
34. Choubdar, N., Golshani, M., Jalili-Baleh, L., Nadri, H., Küçükkilinç, T. T., Ayazgök, B., ... & Khoobi, M. (2019). New classes of carbazoles as potential multi-functional anti-Alzheimer’s agents. Bioorganic Chemistry, 91, 103164. [Google Scholar] [Crossref]
35. Thakur, A., Rana, M., Vanjani, S., Liou, K. C., Taliyan, R., Nepali, K., & Yang, C. H. (2026). Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns. Medicinal research reviews, 46(4), 1173-1229. [Google Scholar] [Crossref]
36. Alka, T. Y. A. G. I. (2025). Novel heterocyclic hybrids as promising scaffold for the management of Alzheimer’s disease. Int J Pharm Pharm Sci, 17(2), 1-15. [Google Scholar] [Crossref]
37. Gontijo, V. S., Viegas, F. P. D., Ortiz, C. J., de Freitas Silva, M., Damasio, C. M., Rosa, M. C., ... & Viegas, C. (2020). Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases. Current neuropharmacology, 18(5), 348-407. [Google Scholar] [Crossref]
38. GOVINDARAJU, T. (2022). Alzheimer's is a Multifactorial. Alzheimer's Disease, 1. [Google Scholar] [Crossref]
39. Patel, D. V., Patel, N. R., Kanhed, A. M., Teli, D. M., Patel, K. B., Joshi, P. D., ... & Yadav, M. R. (2020). Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents. Bioorganic Chemistry, 101, 103977. [Google Scholar] [Crossref]
40. Girase, T. R., & Kapdi, A. R. (2019). Novel Carbazole‐Based N‐Heterocyclic Carbene Ligands to Access Synthetically Relevant Stilbenes in Pd‐Catalyzed Coupling Processes. Chemistry–An Asian Journal, 14(15), 2611-2619. [Google Scholar] [Crossref]
41. Xie, Z., Hu, C., Li, Y., Zhang, L., & Yan, J. (2024). Optimization of quinolinium-carbazole theranostics for the improved photooxidation of β-amyloid aggregates with the variation of conjugation site. Journal of Photochemistry and Photobiology A: Chemistry, 456, 115823. [Google Scholar] [Crossref]
42. Sharon, N., Ugale, V. G., Padmaja, P., Lokwani, D., Salunkhe, C., Shete, P., ... & Kulkarni, P. P. (2025). Development of novel 9 H-carbazole-4 H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer’s disease. Molecular Diversity, 29(1), 379-396. [Google Scholar] [Crossref]
43. Paul, S. K., Goyal, S., Yadav, P., Yadav, S., & Parashari, D. (2013). Phytochemistry and Pharmacological aspects of Murraya koenigii Linn. Research Journal of Pharmacy and Technology, 6(6), 695-697. [Google Scholar] [Crossref]
44. Tharamak, S., Wisarutwanit, T., Songoen, W., Saparpakorn, P., & Pluempanupat, W. (2023). Synthesis and Acetylcholinesterase Inhibitory Evaluation of Coumarin‐Linked Carbazole Derivatives. ChemistrySelect, 8(46), e202303879. [Google Scholar] [Crossref]
45. Gadhave, R. V., & Kuchekar, B. S. (2020). Design, Synthesis, Characterization and Antioxidant activity of Novel Benzothiazole and Coumarin based 6-(3, 5-dimethylpyrazol-1-yl) pyridazin-3-one Derivatives. Research Journal of Pharmacy and Technology, 13(12), 5661-5667. [Google Scholar] [Crossref]
46. Thiratmatrakul, S., Yenjai, C., Waiwut, P., Vajragupta, O., Reubroycharoen, P., Tohda, M., & Boonyarat, C. (2014). Synthesis, biological evaluation and molecular modeling study of novel tacrine–carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 75, 21-30. [Google Scholar] [Crossref]
47. Ravichandra, V. D., Ramesh, C., Swamy, M. K., Purushotham, B., & Rudramurthy, G. R. (2018). Anticancer plants: chemistry, pharmacology, and potential applications. In Anticancer plants: Properties and Application: Volume 1 (pp. 485-515). Singapore: Springer Singapore. [Google Scholar] [Crossref]
48. Wang, G., Sun, S., & Guo, H. (2022). Current status of carbazole hybrids as anticancer agents. European Journal of Medicinal Chemistry, 229, 113999. [Google Scholar] [Crossref]
49. Waghmare, P. S., Chabukswar, A. R., Raut, K. G., & Giri, P. T. (2025). A review on carbazole and its derivatives as anticancer agents from 2013 to 2024. Chirality, 37(2), e70021. [Google Scholar] [Crossref]
50. Çapan, İ., Hawash, M., Jaradat, N., Sert, Y., Servi, R., & Koca, İ. (2023). Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents. BMC chemistry, 17(1), 60. [Google Scholar] [Crossref]
51. Kardile, D., & Shirsat, M. (2021). Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of dihydrobenzimidazole thiopyranooxazinone derivatives. Research Journal of Pharmacy and Technology, 14(3), 1453-1458. [Google Scholar] [Crossref]
52. Al-Samydai, A. M., Almastafa, I. A., Alrabeeah, M. A. A. A., Jabbar, A. A., & Al-Hussaniy, H. A. (2026). Targeted Nanomedicine Approaches for Precision Cancer Therapy. Research Journal of Pharmacy and Technology, 19(1), 472-480. [Google Scholar] [Crossref]
53. Rana, S., Rai, U., Kukreti, N., & Pant, P. (2025). Effect of Eupatorium adenophorum extract on p53 protein in cancer treatment. Research Journal of Pharmacy and Technology, 18(1), 421-426. [Google Scholar] [Crossref]
54. El-Sharkawy, K. A., El-Brrati, M. M., Ghardaly, I. A., & Ali, M. (2015). Design and synthesis of thiazol derivatives with biological evaluations as antitumor agents. Research Journal of Pharmacy and Technology, 8(5), 520. [Google Scholar] [Crossref]
55. Singh, A. K., Kumar, A., Singh, H., Sonawane, P., Paliwal, H., Thareja, S., ... & Kumar, P. (2022). Concept of hybrid drugs and recent advancements in anticancer hybrids. Pharmaceuticals, 15(9), 1071. [Google Scholar] [Crossref]
56. Meenakshisundaram S, Manickam M, Vinayagam V. Design, synthesis and anticancer activity of novel hybrid compounds of imidazopyridine and quinoline/carbazole. Journal of Chemical and Pharmaceutical Research. 2016; 8:576-82. [Google Scholar] [Crossref]
57. Rani, C. S., Reddy, A. G., Susithra, E., Mak, K. K., Pichika, M. R., Reddymasu, S., & Rao, M. V. B. (2021). Synthesis and anticancer evaluation of amide derivatives of imidazo-pyridines. Medicinal Chemistry Research, 30(1), 74-83. [Google Scholar] [Crossref]
58. Kumar, A. (2022). Synthesis and Evaluation of Anticancer activity of some new 3 (2h)-one pyridazinone derivatives by Molecular Docking Studies. Research Journal of Pharmacy and Technology, 15(5), 2279-2284. [Google Scholar] [Crossref]
59. Siddiqui, N., Ahsan, W., Alam, M. S., Azad, B., & Akhtar, M. J. (2011). Newer biologically active pyridines: A potential review. Research Journal of Pharmacy and Technology, 4(12), 1918-1932. [Google Scholar] [Crossref]
60. Bhardwaj, H., Sharma, G. K., Mittal, N., & Bhardwaj, H. (2021). Synthesis and biological evaluation of some newer Indole Derivatives. Research Journal of Pharmacy and Technology, 14(11), 6066-6072. [Google Scholar] [Crossref]
61. Sun, L., Han, L., Zhang, L., Chen, C., & Zheng, C. (2023). Design, synthesis, and antitumor activity evaluation of carbazole derivatives with potent HDAC inhibitory activity. Medicinal Chemistry Research, 32(8), 1677-1689. [Google Scholar] [Crossref]
62. Corona Díaz A, Kurva M, Basavanag U M, Porras G R. Synthesis of Carbazolyl Imidazo [1, 2-a] Pyridines via Groebke-Blackburn-Bienayme Reaction under Green Catalyst. InChem. Proc 2022 (Vol. 4). s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. [Google Scholar] [Crossref]
63. Kasim, S. M., Al-Dabbagh, B. M., & Mustafa, Y. F. (2022). A review on the biological potentials of carbazole and its derived products. Eurasian Chem Commun, 4(6), 495-512. [Google Scholar] [Crossref]
64. Huang, W., Gao, Z., Zhang, Z., Fang, W., Wang, Z., Wan, Z., ... & Ke, S. (2021). Selective and effective anticancer agents: Synthesis, biological evaluation and structure–activity relationships of novel carbazole derivatives. Bioorganic Chemistry, 113, 104991. [Google Scholar] [Crossref]
65. Patil, S. A., Patil, S. A., Ble-González, E. A., Isbel, S. R., Hampton, S. M., & Bugarin, A. (2022). Carbazole derivatives as potential antimicrobial agents. Molecules, 27(19), 6575. [Google Scholar] [Crossref]
66. Chen, C. H., Liu, C. S., Guo, X. M., Tong, J. P., Huang, J., Shi, T. T., & Sun, J. (2024). Design, synthesis, and biological evaluation of carbazole derivatives as potent antibacterial agents targeting membrane function via FabH Inhibition. Journal of Molecular Structure, 1306, 137891. [Google Scholar] [Crossref]
67. Soni, S., Patil, K., Vishwakarma, S., Yadav, R., Murumkar, P. R., & Kadu, R. (2026). Exploring the antimicrobial landscape of carbazole derivatives through integration of computational and experimental approaches. Discover Chemistry, 3(1), 149. [Google Scholar] [Crossref]
68. Shaikh, M. S., Chandrasekaran, B., Palkar, M. B., Kanhed, A. M., Kajee, A., Mlisana, K. P., ... & Karpoormath, R. (2020). Synthesis and biological evaluation of novel carbazole hybrids as promising antimicrobial agents. Chemistry & Biodiversity, 17(5), e1900550. [Google Scholar] [Crossref]
69. Bhupathi, G. M., Padmalatha, K., Anusha, A., Rameeza, A., Sravanthi, M. G., & Praneetha, S. (2016). Synthesis, characterization and antimicrobial activity of acetanilide derivatives by using aromatic aldehydes and sulphonamide derivatives. Research Journal of Pharmacy and Technology, 9(11), 1846. [Google Scholar] [Crossref]
70. Negi, P., Pandey, S., Rawat, B. S., Ramola, B., Kalra, G., & Thakur, R. (2020). Effect of Altitude on Essential Oil composition, Antifeedant and Antimicrobial potential of Murraya koenigii Isolated from different regions of North Himalaya. Research Journal of Pharmacy and Technology, 13(12), 5953-5957. [Google Scholar] [Crossref]
71. Revanasiddappa, B. C., Kumar, M. V., Nayak, P., Ali, A. R., & Jisha, M. S. (2017). Synthesis, antibacterial and antifungal evaluation of novel pyrazoline derivatives. Research Journal of Pharmacy and Technology, 10(5), 1481. [Google Scholar] [Crossref]
72. Çapan, İ., Al, M., Gümüş, M., Açik, L., Aydin, B., Çelik, A. B., ... & Tutar, Y. (2025). Design, Synthesis, and Evaluation of Benzimidazole‐Carbazole Hybrids Targeting Heat Shock Proteins‐Mediated Apoptosis in Breast and Colon Cancer Cells. Drug Development Research, 86(3), e70092. [Google Scholar] [Crossref]
73. Sahu, M., Kumar, V., & Joshi, V. (2021). Indian medicinal plants with antidiabetic potential: An overview. Research Journal of Pharmacy and Technology, 14(4), 2328-2335. [Google Scholar] [Crossref]
74. Çapan, İ., Hawash, M., Qaoud, M. T., & Jaradat, N. (2025). Next-generation carbazole-linked 1, 2, 4-triazole-thione derivatives: strategic design, synthesis, molecular docking, and evaluation of antidiabetic potential. ACS omega, 10(1), 848-861. [Google Scholar] [Crossref]
75. Sahu, P., Sharma, A., & Chatterjee, T. (2010). Natural products with potent hypoglycemic activity. Res J Pharm Technol, 3, 650-656. [Google Scholar] [Crossref]
76. Luo, S., Zhao, L., Peng, H., Peng, Z., & Wang, G. (2024). Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation. European Journal of Medicinal Chemistry, 275, 116600. [Google Scholar] [Crossref]
77. Geronikaki, A. A., & Gavalas, A. M. (2006). Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Combinatorial chemistry & high throughput screening, 9(6), 425-442. [Google Scholar] [Crossref]
78. Gupta, N., Jain, U. K., Jain, A., Lovanshi, G., Mathan, N., & Tiwari, V. (2011). Review of Some Important Medicinal Plants Possesses Anti-Inflammatory Activity. Research journal of Pharmacy and Technology, 4(10), 1506-1512. [Google Scholar] [Crossref]
79. Fernandes, J., Revanasiddappa, B. C., Ishwarbhat, K., Kumar, M. V., D'Souza, L., & Alva, S. S. (2017). Synthesis and in-vitro anti-inflammatory activity of novel pyrazoline derivatives. Research Journal of Pharmacy and Technology, 10(6), 1679. [Google Scholar] [Crossref]
80. Ye, C., Bai, X., Xue, Y., Song, J., Cai, C., Feng, X., & Zhang, T. (2026). Anti‐Inflammatory Activity of Carbazole Derivatives: An In Vitro and In Vivo Study. Chemistry & Biodiversity, 23(4), e03786. [Google Scholar] [Crossref]
81. Pattanashetty, S. H., Hosamani, K. M., Shettar, A. K., & Mohammed Shafeeulla, R. (2018). Design, synthesis and computational studies of novel carbazole n‐phenylacetamide hybrids as potent antibacterial, anti‐inflammatory, and antioxidant agents. Journal of Heterocyclic Chemistry, 55(7), 1765-1774. [Google Scholar] [Crossref]
82. Dai, T. L., Mou, G. L., Liang, H. J., Li, X., Luo, X. F., Zhang, B. Q., ... & Liu, Y. Q. (2026). Design, synthesis, and study of prenylated carbazole derivatives as potential antimicrobial agents. Journal of Agricultural and Food Chemistry, 74(1), 486-499. [Google Scholar] [Crossref]
83. Bandgar, B. P., Adsul, L. K., Chavan, H. V., Jalde, S. S., Shringare, S. N., Shaikh, R., ... & Masand, V. (2012). Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents. Bioorganic & medicinal chemistry letters, 22(18), 5839-5844. [Google Scholar] [Crossref]